IP Library Patent Application 13006485
Patent Application
App. No. 13/006,485

Salts of N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/006,485
Abstract

Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide are prepared and characterized.

Claims (11)

1 . The salt of —N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide, wherein the salt is a lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl) ethyl]amino]methyl]phenyl]-2E-2-propenamide.

2 . The salt of claim 1 , wherein the lactate salt is a 1:1 lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl) ethyl]amino]methyl]phenyl]-2E-2-propenamide.

3 . The salt of claim 1 , wherein the lactate salt is a monohydrate lactate salt.

4 . The salt of claim 1 , wherein the lactate salt is an anhydrous lactate salt.

5 . The salt of claim 1 , wherein the lactate salt is a DL-lactate salt.

6 . The salt of claim 5 , wherein the DL-lactate salt is a monohydrate DL-lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

7 . The salt of claim 5 , wherein the DL-lactate salt is an anhydrous DL-lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

8 . The salt of claim 1 , wherein the lactate salt is an L-lactate salt.

9 . The salt of claim 8 , wherein the L-lactate salt is an anhydrous L-(+)-lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

10 . The salt of claim 1 , wherein the lactate salt is a D-lactate salt.

11 . The salt of claim 10 , wherein the D-lactate salt is an anhydrous D-(−)-lactate salt of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

Assignments (4)
RELEASE OF IP SECURITY INTEREST AT REEL/FRAME 048510/0364 Recorded Oct 31, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SECURA BIO, INC.
Reel/Frame 061814/0821 →
CONFIRMATORY ASSIGNMENT Recorded May 21, 2019
From: NOVARTIS AG
To: SECURA BIO, INC.
Reel/Frame 049246/0720 →
SECURITY INTEREST Recorded Mar 5, 2019
From: SECURA BIO, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048510/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2019
From: NOVARTIS PHARMA AG
To: SECURA BIO, INC.
Reel/Frame 048477/0661 →